BACKGROUND: Silent brain infarcts (SBIs) and white matter hyperintensities are subclinical cerebrovascular lesions associated with incident stroke and cognitive decline. Left ventricular ejection fraction (LVEF) is a predictor of stroke in patients with heart failure, but its association with subclinical brain disease in the general population is unknown. Left ventricular global longitudinal strain (GLS) can detect subclinical cardiac dysfunction even when LVEF is normal. We investigated the relationship of LVEF and GLS with subclinical brain disease in a community-based cohort. METHODS AND RESULTS: LVEF and GLS were assessed by 2-dimensional and speckle-tracking echocardiography in 439 participants free of stroke and cardiac disease from the Cardiovascular Abnormalities and Brain Lesions (CABL) study. SBIs and white matter hyperintensities were assessed by brain MRI. Mean age of the study population was 69±10 years, 61% were women, LVEF was 63.8±6.4%, GLS was -17.1±3.0%. SBIs were detected in 53 participants (12%), white matter hyperintensity volume was 0.63±0.86%. GLS was significantly lower in participants with SBI versus those without (-15.7±3.5% versus -17.3±2.9%, P<0.01), whereas no difference in LVEF was observed (63.3±8.6% versus 63.8±6.0%, P=0.60). In multivariate analysis, lower GLS was associated with SBI (odds ratio/unit decrease=1.18; 95% confidence interval, 1.05-1.33; P<0.01), whereas LVEF was not (odds ratio/unit increase=1.00; 95% confidence interval, 0.96-1.05; P=0.98). Lower GLS was associated with greater white matter hyperintensity volume (adjusted β=0.11, P<0.05), unlike LVEF (adjusted β=-0.04, P=0.42). CONCLUSIONS: Lower GLS was independently associated with subclinical brain disease in a community-based cohort without overt cardiac disease. GLS can provide additional information on cerebrovascular risk burden beyond LVEF assessment.
BACKGROUND:Silent brain infarcts (SBIs) and white matter hyperintensities are subclinical cerebrovascular lesions associated with incident stroke and cognitive decline. Left ventricular ejection fraction (LVEF) is a predictor of stroke in patients with heart failure, but its association with subclinical brain disease in the general population is unknown. Left ventricular global longitudinal strain (GLS) can detect subclinical cardiac dysfunction even when LVEF is normal. We investigated the relationship of LVEF and GLS with subclinical brain disease in a community-based cohort. METHODS AND RESULTS: LVEF and GLS were assessed by 2-dimensional and speckle-tracking echocardiography in 439 participants free of stroke and cardiac disease from the Cardiovascular Abnormalities and Brain Lesions (CABL) study. SBIs and white matter hyperintensities were assessed by brain MRI. Mean age of the study population was 69±10 years, 61% were women, LVEF was 63.8±6.4%, GLS was -17.1±3.0%. SBIs were detected in 53 participants (12%), white matter hyperintensity volume was 0.63±0.86%. GLS was significantly lower in participants with SBI versus those without (-15.7±3.5% versus -17.3±2.9%, P<0.01), whereas no difference in LVEF was observed (63.3±8.6% versus 63.8±6.0%, P=0.60). In multivariate analysis, lower GLS was associated with SBI (odds ratio/unit decrease=1.18; 95% confidence interval, 1.05-1.33; P<0.01), whereas LVEF was not (odds ratio/unit increase=1.00; 95% confidence interval, 0.96-1.05; P=0.98). Lower GLS was associated with greater white matter hyperintensity volume (adjusted β=0.11, P<0.05), unlike LVEF (adjusted β=-0.04, P=0.42). CONCLUSIONS: Lower GLS was independently associated with subclinical brain disease in a community-based cohort without overt cardiac disease. GLS can provide additional information on cerebrovascular risk burden beyond LVEF assessment.
Entities:
Keywords:
brain infarction; echocardiography; global longitudinal strain; magnetic resonance imaging; speckle-tracking; ventricular ejection fraction; white matter diseases
Authors: T R Price; T A Manolio; R A Kronmal; S J Kittner; N C Yue; J Robbins; H Anton-Culver; D H O'Leary Journal: Stroke Date: 1997-06 Impact factor: 7.914
Authors: T A Manolio; G L Burke; D H O'Leary; G Evans; N Beauchamp; L Knepper; B Ward Journal: Arterioscler Thromb Vasc Biol Date: 1999-02 Impact factor: 8.311
Authors: Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio Journal: Echocardiography Date: 2013-01-30 Impact factor: 1.724
Authors: Cesare Russo; Fusako Sera; Zhezhen Jin; Vittorio Palmieri; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio Journal: Eur J Heart Fail Date: 2016-04-24 Impact factor: 15.534
Authors: Nathan F Johnson; Brian T Gold; Alison L Bailey; Jody L Clasey; Jonathan G Hakun; Matthew White; Doug E Long; David K Powell Journal: Neuroimage Date: 2015-05-30 Impact factor: 6.556
Authors: Christa A Hammond; Natalie J Blades; Sarwat I Chaudhry; John A Dodson; W T Longstreth; Susan R Heckbert; Bruce M Psaty; Alice M Arnold; Sascha Dublin; Colleen M Sitlani; Julius M Gardin; Stephen M Thielke; Michael G Nanna; Rebecca F Gottesman; Anne B Newman; Evan L Thacker Journal: Circ Heart Fail Date: 2018-03 Impact factor: 8.790
Authors: Regina von Rennenberg; Bob Siegerink; Ramanan Ganeshan; Kersten Villringer; Wolfram Doehner; Heinrich J Audebert; Matthias Endres; Christian H Nolte; Jan F Scheitz Journal: J Neurol Date: 2018-10-11 Impact factor: 4.849
Authors: Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio Journal: Am Heart J Date: 2015-02-21 Impact factor: 4.749
Authors: Kasra Moazzami; Mohammad Reza Ostovaneh; Bharath Ambale Venkatesh; Mohammadali Habibi; Kihei Yoneyama; Colin Wu; Kiang Liu; Isabel Pimenta; Annette Fitzpatrick; Steven Shea; Robyn L McClelland; Susan Heckbert; Rebecca F Gottesman; David A Bluemke; Timothy M Hughes; João A C Lima Journal: Hypertension Date: 2018-01-29 Impact factor: 10.190
Authors: Cesare Russo; Zhezhen Jin; Fusako Sera; Edward S Lee; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio Journal: Circ Cardiovasc Imaging Date: 2015-08 Impact factor: 7.792